JPMorgan Chase & Co. assumed coverage on shares of Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) in a report issued on Thursday, MarketBeat Ratings reports. The brokerage set an “overweight” rating on the stock.
Ascentage Pharma Group International Stock Up 7.2 %
NASDAQ AAPG opened at $21.65 on Thursday. Ascentage Pharma Group International has a 12 month low of $16.50 and a 12 month high of $22.43.
Ascentage Pharma Group International Company Profile
See Also
- Five stocks we like better than Ascentage Pharma Group International
- Best Aerospace Stocks Investing
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Top Biotech Stocks: Exploring Innovation Opportunities
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
